Understanding Insulin Resistance in the Arab Population: Causes, Diagnosis & Care

Insulin Resistance in the Arab Population of the Gulf: Causes, Diagnosis, Prevention and Care

1. Introduction & regional context

Insulin resistance (IR) is a central metabolic abnormality that precedes and promotes type 2 diabetes, metabolic syndrome and cardiovascular disease. In the Gulf Cooperation Council (GCC) countries, rapid socioeconomic change over recent decades has been accompanied by a marked rise in obesity, sedentary lifestyles, and cardiometabolic disease burden. Regional estimates and epidemiological reviews indicate that the prevalence of diabetes and metabolic abnormalities in Gulf populations is higher than many global averages, creating an urgent need for prevention and early detection strategies tailored to local realities. ([diabetesatlas.org](https://www.diabetesatlas.org/data/upload/download/global_factsheet_en.pdf?utm_source=openai))

Addressing IR in the Gulf is important for two practical reasons: first, to guide public health planning (population screening, primary care pathways, policy actions), and second, to optimize individual clinical care for people with obesity, dyslipidemia, or impaired glucose regulation. National surveys and regional meta-analyses show high and growing rates of metabolic syndrome components and obesity across age groups — trends that predict increasing IR-related complications unless systems-level changes occur. ([stats.gov.sa](https://www.stats.gov.sa/sites/default/files/Health-Determinants-Statistics-Publication-2023-1EN.pdf?utm_source=openai))

Key message: Combating insulin resistance in the Gulf requires combining early screening, culturally adapted lifestyle programs, and supportive public policies.

2. What is insulin resistance? Simple biological mechanisms and systemic effects

Insulin resistance is defined by a reduced biological response of tissues — primarily skeletal muscle, adipose tissue, and liver — to th